US Patent Issued to EMPYREAN NEUROSCIENCE on Sept. 22 for "Genetic engineering of fungi to modulate tryptamine expression" (New York Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,160, issued on Sept. 22, was assigned to EMPYREAN NEUROSCIENCE INC. (New York).

"Genetic engineering of fungi to modulate tryptamine expression" was invented by Thomas Henley (New York), Modassir Choudhry (New York) and Jose Fernandez-Gomez (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for modulating the psilocybin biosynthesis pathway in fungi or other organisms. Also provided are genetically modified fungi and organisms with induced and/or increased expression of psilocybin and psilocin and psilocybin and/or psilocin compositions generated by the provided methods."

The patent was filed on April 1, 2022, und...